Floatz logo

CARMUSTINE

Aplastic Anemia

Texas Oncology Cancer CenterSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the Aplastic Anemia cohort.

Asset / SponsorPhaseRating
Fludarabine
Thomas Jefferson University
Phase 2BBB
Cyclophosphamide
Thomas Jefferson University
Phase 3BBB
TACROLIMUS
Thomas Jefferson University
Phase 2BB
FILGRASTIM
Thomas Jefferson University
Phase 2BB
Monomethyl Fumarate
Thomas Jefferson University
Phase 2BB

View all 36 →

Same molecule, other indications

CARMUSTINE is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
74 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
B-cell non-Hodgkin lymphomaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →